Irena is the Chief Financial Officer at aMoon, where she is responsible for all of the Fund's financial functions, including reporting, treasury and corporate finance.
Irena brings over 15 years of finance management experience in public companies and business units of global enterprises. She oversees the finance and operations support provided to all functions within the organization, assisting senior management in financial planning and results management, she leads financial and tax due diligence processes, and analyzes portfolio companies financial and business results.
Prior to joining aMoon, Irena was the VP of Finance at Alcobra (NASDAQ: ADHD) a development-stage biotech company, where she led the financial aspects of Alcobra’s operations, playing a key role in Public equity offering and Alcobra’s merger with Arcturus Therapeutics (NASDAQ: ARCT), a San-Diego based mRNA company.
Prior to joining Alcobra, she was Finance Manager at Omrix Biopharmaceuticals, a Johnson & Johnson company, where she spent seven years in various finance positions.
Irena is passionate about being part of an organization that enables companies to develop technologies which may save lives.
Irena is a Certified Public Accountant and holds a B.A. in Economics and Accounting from the Hebrew University of Jerusalem and an M.B.A. from Tel Aviv University.